APA (7th ed.) Citation

P, C., Y, W., Y, L., N, J., L, Z., X, M., . . . S, L. (2019). PI3K p110α inhibition sensitizes cervical cancer cells with aberrant PI3K signaling activation to PARP inhibitor BMN673. Oncology reports, 42(5), 2097. https://doi.org/10.3892/or.2019.7313

Chicago Style (17th ed.) Citation

P, Cao, et al. "PI3K P110α Inhibition Sensitizes Cervical Cancer Cells with Aberrant PI3K Signaling Activation to PARP Inhibitor BMN673." Oncology Reports 42, no. 5 (2019): 2097. https://doi.org/10.3892/or.2019.7313.

MLA (9th ed.) Citation

P, Cao, et al. "PI3K P110α Inhibition Sensitizes Cervical Cancer Cells with Aberrant PI3K Signaling Activation to PARP Inhibitor BMN673." Oncology Reports, vol. 42, no. 5, 2019, p. 2097, https://doi.org/10.3892/or.2019.7313.